The European Energy Using Products Directive (EuP) (2005/32/EC) establishes a framework to allow the EU Commission to target powered products that have a significant environmental impact by virtue of their energy consumption and distribution.
The objective of the Directive is to try and manage the reduction in environmental impact of energy using products by identifying product groups (eg. products with a stand-by mode, office lighting, 'white' goods, etc) that, in total, consume significant amounts of energy.
The Commission will then study the results of this first phase to establish whether there is a significant environmental benefit from controlling the environmental impact of that group. If so ‘implementing measures’ will be drawn up, with which products covered by the group must comply.
This Directive is in the early stages of implementation, so few product groups have so far been identified; however equipment with stand-by modes, and incandescent light bulbs are expected to be among the first to feature.
For companies that manufacture electromedical equipment, the publication of a new collateral standard in the IEC 60601 series (IEC 60601-1-9:2007, 'Environmentally Conscious Design of Medical Electrical Equipment', heralds the start of growing expectation that device manufacturers should be taking steps at the design stage to minimize the environmental impact of their devices.
Our Environmental Systems Specialist, who was a member of the International Working Group that developed the IEC 60601-1-9 Standard, can help you:
  • Understand the background and requirements of the standard

  • Achieve device by device compliance with the standard

  • Develop standard operating procedures to comply with IEC 60601-1-9

  • Keep up-to-date with developments concerning the EuP Directive and any implementing measures

Contact us for more information on how GEMARMED can help you manage current and future regulatory and user expectations on environmentally concious design, or to talk with our Environmental Systems Specialist.